Birch pollen allergen extract (Allergopharma)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameBirch pollen allergen extract (Allergopharma)
Drug Alias NameAL-0206st
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermany
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergopharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic +[4

Other Information

ATC CodeN/A
Related LinksN/A